Prostate Cancer - Results from #23100

Bone metastases and bone loss medical treatment in prostate cancer patients - Abstract May 28, 2013

Low-risk prostate cancer patients without visible tumor (T1c) on multiparametric MRI could qualify for active surveillance candidate even if they did not meet inclusion criteria of active surveillance protocol - Abstract May 28, 2013

Focal ablation of prostate cancer: Four roles for magnetic resonance imaging guidance - Abstract May 28, 2013

Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08) - Abstract May 28, 2013

Trends and estimates in prostate cancer incidence, mortality and prevalence in the Slovak Republic, 1968-2012 - Abstract May 28, 2013

Metabolic and toxicological considerations of newly approved prostate cancer drugs - Abstract May 28, 2013

Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone - Abstract May 28, 2013

Prostate-specific antigen bounce after high-dose-rate monotherapy for prostate cancer - Abstract May 27, 2013

Prostate and patient intrafraction motion: Impact on treatment time-dependent planning margins for patients with endorectal balloon - Abstract May 27, 2013

Pelvic lymph node dissection during robot-assisted radical prostatectomy: Efficacy, limitations, and complications-A systematic review of the literature - Abstract May 27, 2013

Locally advanced and metastatic prostate cancer treated with intermittent androgen monotherapy or maximal androgen blockade: Results from a randomised phase 3 study by the South European Uroncological Group - Abstract May 27, 2013

Monitoring brain activation changes in the early postoperative period after radical prostatectomy using fMRI - Abstract May 27, 2013

Prostatic swelling and shift during high-intensity focused ultrasound: Implication for targeted focal therapy - Abstract May 27, 2013

The effect of anterior proton beams in the setting of a prostate-rectum spacer - Abstract May 25, 2013

Necessity analysis of bone scan in patients with newly diagnosed prostate cancer - Abstract May 25, 2013

High dose rate prostate brachytherapy - Abstract May 25, 2013

Prostate cancer diagnosis: Multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--Prospective multicenter study - Abstract May 24, 2013

5-Alpha reductase inhibitors in patients on active surveillance: Do the benefits outweigh the risk? - Abstract May 24, 2013

(11)C-Choline PET/CT and PSA kinetics - Abstract May 24, 2013

Cabazitaxel for the second-line treatment of metastatic hormone-refractory prostate cancer: A NICE single technology appraisal - Abstract May 24, 2013

Page 1156 of 1435